nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Absence of antigenic competition in Aotus monkeys immunized with Plasmodium falciparum DNA vaccines delivered as a mixture
|
Jones, Trevor R |
|
2002 |
20 |
11-12 |
p. 1675-1680 6 p. |
artikel |
2 |
Adverse event reports following vaccination for Lyme disease: December 1998–July 2000
|
Lathrop, Sarah L. |
|
2002 |
20 |
11-12 |
p. 1603-1608 6 p. |
artikel |
3 |
Alphavirus replicon particles expressing the two major envelope proteins of equine arteritis virus induce high level protection against challenge with virulent virus in vaccinated horses
|
Balasuriya, Udeni B.R. |
|
2002 |
20 |
11-12 |
p. 1609-1617 9 p. |
artikel |
4 |
Analysis of recombinant mouse zona pellucida protein 2 (ZP2) constructs for immunocontraception
|
Lea, Isabel A. |
|
2002 |
20 |
11-12 |
p. 1515-1523 9 p. |
artikel |
5 |
Application of heat killed Mycobacterium bovis-BCG into the lung inhibits the development of allergen-induced Th2 responses
|
Major Jr., Tamás |
|
2002 |
20 |
11-12 |
p. 1532-1540 9 p. |
artikel |
6 |
A review of emergency foot-and-mouth disease (FMD) vaccines
|
Barnett, P.V |
|
2002 |
20 |
11-12 |
p. 1505-1514 10 p. |
artikel |
7 |
Clinical trial of the intradermal administration of hepatitis B vaccine produced at the Department of Medical Research, Myanmar
|
Kyi, Khin Pyone |
|
2002 |
20 |
11-12 |
p. 1649-1652 4 p. |
artikel |
8 |
Detection of measles vaccine in the throat of a vaccinated child
|
Morfin, Florence |
|
2002 |
20 |
11-12 |
p. 1541-1543 3 p. |
artikel |
9 |
Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24
|
Moraes, M.P |
|
2002 |
20 |
11-12 |
p. 1631-1639 9 p. |
artikel |
10 |
Enhanced immune protection by a liposome-encapsulated recombinant respiratory syncytial virus (RSV) vaccine using immunogenic lipids from Deinococcus radiodurans
|
Huang, Yan |
|
2002 |
20 |
11-12 |
p. 1586-1592 7 p. |
artikel |
11 |
Evidence based vaccinology
|
Nalin, David R |
|
2002 |
20 |
11-12 |
p. 1624-1630 7 p. |
artikel |
12 |
Experimental non-transmissible marker vaccines for classical swine fever (CSF) by trans-complementation of Erns or E2 of CSFV
|
van Gennip, H.G.P |
|
2002 |
20 |
11-12 |
p. 1544-1556 13 p. |
artikel |
13 |
Genetic and immunological comparison of anti-botulinum type A antibodies from immune and non-immune human phage libraries
|
Amersdorfer, Peter |
|
2002 |
20 |
11-12 |
p. 1640-1648 9 p. |
artikel |
14 |
Immunization of T-cell deficient mice against polyomavirus infection using viral pseudocapsids or temperature sensitive mutants
|
Heidari, Shirin |
|
2002 |
20 |
11-12 |
p. 1571-1578 8 p. |
artikel |
15 |
Immunogenicity of a recombinant varicella-zoster virus gE–IE63 fusion protein, a putative vaccine candidate against primary infection and zoster reactivation
|
Jacquet, Alain |
|
2002 |
20 |
11-12 |
p. 1593-1602 10 p. |
artikel |
16 |
Immunogenicity of Hepatitis B vaccine in preterm and full term infants vaccinated within the first week of life
|
Freitas da Motta, Márcia Soares |
|
2002 |
20 |
11-12 |
p. 1557-1562 6 p. |
artikel |
17 |
Immunogenicity of χ4127 phoP− Salmonella enterica serovar Typhimurium in dogs
|
McVey, D.Scott |
|
2002 |
20 |
11-12 |
p. 1618-1623 6 p. |
artikel |
18 |
Immunogenicity of the Brucella melitensis recombinant ribosome recycling factor-homologous protein and its cDNA
|
Cassataro, Juliana |
|
2002 |
20 |
11-12 |
p. 1660-1669 10 p. |
artikel |
19 |
Intranasal inoculation of a recombinant influenza virus containing exogenous nucleotides in the NS segment induces mucosal immune response against the exogenous gene product in mice
|
Takasuka, Naomi |
|
2002 |
20 |
11-12 |
p. 1579-1585 7 p. |
artikel |
20 |
Letter to the editor
|
Heininger, U |
|
2002 |
20 |
11-12 |
p. 1480- 1 p. |
artikel |
21 |
Monoclonal antibody protects mice against infection and disease when given either before or up to 24 h after airborne challenge with virulent Venezuelan equine encephalitis virus
|
Phillpotts, R.J |
|
2002 |
20 |
11-12 |
p. 1497-1504 8 p. |
artikel |
22 |
Nasal mucosal immunogenicity for the horse of a SeM peptide of Streptococcus equi genetically coupled to cholera toxin
|
Sheoran, A.S |
|
2002 |
20 |
11-12 |
p. 1653-1659 7 p. |
artikel |
23 |
Oral immunization of mice with ricin toxoid vaccine encapsulated in polymeric microspheres against aerosol challenge
|
Kende, Meir |
|
2002 |
20 |
11-12 |
p. 1681-1691 11 p. |
artikel |
24 |
Protection against feline immunodeficiency virus using replication defective proviral DNA vaccines with feline interleukin-12 and -18
|
Dunham, Stephen P |
|
2002 |
20 |
11-12 |
p. 1483-1496 14 p. |
artikel |
25 |
Protective efficacy of a plasmid DNA encoding Japanese encephalitis virus envelope protein fused to tissue plasminogen activator signal sequences: studies in a murine intracerebral virus challenge model
|
Ashok, Mundrigri S |
|
2002 |
20 |
11-12 |
p. 1563-1570 8 p. |
artikel |
26 |
Protective immune responses elicited in mice by immunization with formulations of poly(lactide-co-glycolide) microparticles
|
McKeever, U |
|
2002 |
20 |
11-12 |
p. 1524-1531 8 p. |
artikel |
27 |
Strengthening immunization systems and introduction of hepatitis B vaccine in central and eastern Europe and the Newly Independent States
|
FitzSimons, D. |
|
2002 |
20 |
11-12 |
p. 1475-1479 5 p. |
artikel |
28 |
Supplementation of conventional trivalent influenza vaccine with purified viral N1 and N2 neuraminidases induces a balanced immune response without antigenic competition
|
Johansson, Bert E |
|
2002 |
20 |
11-12 |
p. 1670-1674 5 p. |
artikel |
29 |
What is a safe vaccine?
|
Steele, Duncan |
|
2002 |
20 |
11-12 |
p. 1481-1482 2 p. |
artikel |